05 Aug, EOD - Indian

Nifty Pharma 21970.15 (-0.83)

Nifty IT 35034.5 (-0.48)

SENSEX 80710.25 (-0.38)

Nifty Midcap 100 57206.85 (-0.39)

Nifty 50 24649.55 (-0.30)

Nifty Next 50 66762.05 (-0.23)

Nifty Smallcap 100 17864.55 (-0.16)

Nifty Bank 55360.25 (-0.47)

05 Aug, EOD - Global

NIKKEI 225 40605.82 (0.14)

HANG SENG 24922.54 (0.08)

S&P 6334 (-0.05)

LOGIN HERE

companylogo

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Chairman's Speech

Dear Members

We have range of single and multiple herbal and sea based formulations. Clinically validated products provide the details of safety and efficacy. These clinically validated products install sufficient confidence among consumers as they get appropriate value for their money. Celestial plans to have at least 25 clinically validated multiple herbal formulations that can get certification from CCRAS, Ministry of Ayush.

Biophrama scenario and our products

Anti diabetes formulations derived from sea weed extract is clinically tested and patented products. This product is making penetration in Indian market .Anti arthritis and Biovita have already made an established mark in the market .Herbal and Enzyme formulations can also be marketed worldwide by using online platform along with off line present marketing activities, We are moving in synergy by improving our supply chain and also introducing new control measures. We have already started advertising our Lead research product called Cadalmin GAE, Our effort is continuing to establish OTC market for all our products. We shall spread our domestic marketing in another 12 states during the next year

Biopharmaceutical in India and rest of the world has made significant improvement. We are addressing with great care to revamp our business model. Pharma industry shall be able to keep the pace with the good quality products as there is always demand for such quality pharma products. Our most of the products are very effective and we are making every effort to meet the demand. We are developing effective supply chain management by introducing new distributors and stockiest at different places. We are also introducing incentive scheme to stockist sales person in order to increase the volume of sales

The biopharmaceutical market is highly competitive. In order to have a competitive edge, our facility at Biotech park, an integrated facility clubbed with R&D and product development of innovative project shall be the key factor. We will continue to pursue our R&D initiative in peptide, Enzymes and protein and proceed with manufacturing of these products at new facility at SEZ, Biotech park. This will provide us an opportunity to market our products in Domestic and overseas market.

Initiative

Every effort and established processes are in place towards brand building and advertising to handle OTC marketing, We are able to build better volume by Strengthening the manufacturing, marketing and distribution We are in the process of meeting WHO stamping on the premier products and that shall provide us an opportunity to market our products in African and south East Asian countries attracting premier pricing.. Reaching everywhere through C&F and distributors is an difficult proposition and online sales will take us at every corner of India. Feed supplement to cattle s, poultry and fisheries is an major task to us and celestial is continuously trying to improve the reach and increase the range of feed supplements in order to spread the sale of feed supplements across India.

Effective Human Resource

This aspect is a recognized tool to increase productivity. Effective and Quality manpower and their retention is always an challenging task and addressing this task carefully shall increase the productivity. We have taken very careful steps to retain only quality, dedicated and efficient staff. Training courses and sending them to various seminars and symposium shall also be our priority and thus we will ensure professional skill development. We have taken a Person with Company secretary and chartered accountancy qualification and also are in the process of recruiting Business development and Research and developmental professionals

Research initiatives and collaborative effort

Innovation and development cost is becoming more and more and day by day and it needs an optimization effort to reduce the cost..Collaborative research is essential for a company like us so that we can always fulfill our research objective most economically and effectively. We are also developing collaborations with CSIR and ICAR and ICMR and Universities and institutions to develop the Biotech products. Collaborative research projects with these premier research organization shall provide a competitive edge and also increase our learning graph having association with very experienced Research scientists of these prominent institutions.. We are also installing software at each C&F in all the states to make our monitoring and control more effective.ly We are making every effort to complete the remaining work at city and Biotech park facility so that production, supply chain can be improved in order to increase the business volume. CMFRI Kochin association has given us Cadalmin, a great product. Cadalmin efficacy is so high that people suffering from arthritis are getting tremendous relief. Further we are moving to launch a much needed research product to treat diabetes. Lalita college of pharmacy having extremely good animal house and accredited testing facility have been identified as one of the clinical research partner to conduct animal testing for our Ayush approved products.

Value to the shareholders

Shareholders are very important to us. We always keep shares holders interest on priority and would like to ensure all our shares holders shall be benefitted immensely. Increasing the investor wealth is our top priority and we will make rapid progress towards achieving our objective once our capital project is completed. We always address any complaint by shareholders very promptly in order to increase share holders value, we are in the process of reorganizing our research and manufacturing.

Corporate Social responsibility

Good industries need to support social cause. We are providing medicines on avery concessional rate to under privileged and handicap people who cannot afford to buy the expensive medicines. This distribution is being done in villages through AWAKE RESEARCH and SERVICE FOUNDATION, a voluntary and social organization. We are also making effort to buy herbal raw material from farmers driven source directly by giving value to farmers and also ensuring good quality of raw material. There is very good response from farmers to work on contract farming to grow medicinal plants and shall be moving shortly to have such agreement with farmers cooperative society. Developing raw material through contract farming by involving farmers shall be our continuous effort so that farmers can be benefitted.

Acknowledgment

We always appreciate and acknowledge the valuable input and advice from our shareholders, we thank all our shareholders, stake holders, staff and business associates for their continued support and look forward to your valuable advice to achieve our objective at regular interval

Dr A N Singh

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +